Please wait
Healthcare · Medical Instruments & Supplies · Price, fundamentals, signals, and forward-looking context in one research view.
Healthcare
$13.6B
N/A
59.24
Current price
$70.01
-1.6% todayUpdated just now
Open
$71.18
Previous close
$71.17
Day range
$69.64 – $71.51
Volume
N/A
59.2x P/E
Awaiting filing
No current yield
65/100 measured
Easy to trade
Recent price movement, key market context and the latest company information.
The latest saved price history for COO, with its range and direction at a glance.
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Investors usually follow COO for its valuation signal, sector position, and upcoming company events. The goal here is not just to show numbers, but to explain what they mean in plain English.
Whisone is bearish because the bullish case is not yet strong enough to lead while fundamentals are weak at 44/100. Whisone has low conviction here. The final read is being balanced by the weighted scores for fundamentals, technicals, insider flow, sentiment, event flow, and liquidity.
Whisone v2 splits the read into weighted parts so the score is not just one hidden number.
Fundamentals
Growth, margins, cash flow, and valuation.
Latest net profit
-$77.9M
TTM (2026-04-30)
ROE
2.9%
Return on equity
ROA
2.5%
Return on assets
Debt / equity
0.30
Lower is usually safer.
P/B ratio
1.65
Useful for book value support.
84/100
Direction
Range-bound
Main supports
Recent price and fundamentals refreshes improve signal reliability.
What can go wrong
Execution risk and market swings can still delay the forecast playing out.
Fair value
$76.33
Analyst view
Buy
Analyst target
$81.50
Forecast refresh
Updated 12h ago
Quality score
49
Growth score
50
These are the external analyst numbers and business outlook figures already synced into the company record.
No external analyst outlook is available for this company yet.
$0.01
2020-07-22
Payment: TBA | Qualification: 2020-07-22 | Yield at declaration: N/A
$0.01
2020-01-22
Payment: TBA | Qualification: 2020-01-22 | Yield at declaration: N/A
A plain-English reading of momentum, trend, volatility, range position, and trading participation.
RSI
N/A
Momentum data is not available yet.
Recent trend
Falling
-3.2% across the latest saved price window.
Volatility
Moderate
Beta is 0.82. Price sensitivity is broadly around the market range.
52-week position
36% of range
Price is sitting around the middle of its 52-week range.
Volume confirmation
N/A
Comparable volume data is not available.
AbbVie Inc.
Price: $256.14
P/E: 72.994286
Yield: 2.7%
ABT
Abbott Laboratories
Price: $110.19
P/E: 36.39806
Yield: 2.3%
ALGN
Align Technology, Inc.
Price: $157.96
P/E: 27.310226
Yield: 0.0%
Industry
Medical Instruments & Supplies
Employees
15000
Exchange
NMS
Ticker
COO
